Human Cloning Isn’t Monkey Business
By Osagie K. Obasogie,
Genetic Crossroads
| 11. 29. 2007
Rarely have science, politics, and international diplomacy converged as intensely as they have over the past few days.
Researchers at the Oregon National Primate Research Center have accomplished what some scientists equate with breaking the sound barrier: creating cloned embryos from an adult monkey and isolating its stem cells. Since monkeys are humans' closest relatives and embryonic stem cells might treat devastating injuries and diseases, this research has invigorated prospects for developing patient-specific embryonic stem cells for humans by copying the Oregon researchers' new approach. After all, monkey see, monkey do.
Yet another level of intrigue comes from the fact that cloning an embryo to obtain stem cells involves the same underlying process as cloning an embryo to create a living, breathing clone: taking the nucleus from a body cell, sticking it into an egg, and triggering its early development. Research cloning involves stopping this development after a few days to cull the early embryos' stem cells; reproductive cloning entails placing the developing embryo into a surrogate until the clone is born.
Scientists have not yet created a living cloned...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...
